Chef Pepin becomes the newest face of Navarro Discount Pharmacies
MIAMI — Navarro Discount Pharmacies has tapped a TV personality to serve as its celebrity spokesman.
Chef Pepin now is part of Navarro’s overall marketing campaign and expansion strategy, the Miami-based drug store chain said. In addition to promoting a healthy lifestyle to Navarro’s customers through in-store demonstrations and other outreach efforts, Pepin will assist with the promotion of the company’s extensive line of household appliances — currently available in stores and soon to be available online.
The healthy-eating promotion is part of Navarro’s Diabetes Club, which focuses on nutrition, exercise and prevention for adults and children, the retailer said. “Chef Pepin is an icon to Hispanics and Latinos everywhere,” said Steve Kaczynski, Navarro Discount Pharmacies CEO. “Together, we will educate Hispanics about adopting a healthier approach to food and how to cook healthy.”
Highlighting health observance, United Supermarkets offers flu vaccine special to customers
LUBBOCK, Texas — United Supermarkets’ family of stores is recognizing National Influenza Vaccination Week by offering customers a $20 flu vaccine special.
The national observance, which runs from Dec. 5 through Dec. 11, was established to highlight the importance of continuing influenza vaccination, as well as fostering greater distribution of the flu vaccine during the holiday season, into January and beyond, , according to the Centers for Disease Control and Prevention. The vaccine will be offered at United Supermarkets, Market Street and Amigos United pharmacies.
"We are reducing the cost of our influenza vaccine during this time in an effort to vaccinate more of our guests and help promote a healthy, flu-free holiday season," said Tim Purser, business director pharmacy for United Supermarkets. "An annual flu shot is the first and best step toward prevention of the flu."
With drug’s FDA approval, Sagent expands oncology portfolio
SCHAUMBURG, Ill. — The Food and Drug Administration has approved a generic chemotherapy drug made by Sagent Pharmaceuticals, Sagent said Thursday.
The FDA approved topotecan hydrochloride for injection, a version of GlaxoSmithKline’s Hycamtin. The U.S. market for injectable topotecan was around $158 million in 2010, according to IMS Health.
“Topotecan is an important treatment for patients who have recurrent small-cell lung cancer sensitive disease or cervical cancer,” Sagent chairman and CEO Jeffrey Yordon said. “Our launch of topotecan reinforces Sagent’s commitment to grow our oncology portfolio, to meet the needs of oncology patients and clinicians, and to demonstrate our capabilities and expertise in injectable pharmaceuticals.”